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Method
• A review was conducted (Figure 
1) using the guidelines published 
by the Centre for Reviews & 
Dissemination (CRD’s Guidance 
for Undertaking Reviews in 
Health Care, 2009). 
• Two databases were used:
1. EBSCO Host Academic 
Search Complete 
2. Google Scholar 
• Search terms (used in varying 
combinations): “the metabolic 
effects of caffeine”, 
“carbohydrates”, “proteins”, 
“metabolism” and “insulin 
response to caffeine” 
• Research databases were 
searched between July 2015 and 
April 2016 
• Summarized based on specific 
research characteristics 
Introduction
Inspired by the profound use of 
everyday caffeine consumption in 
the United States, our group is 
interested in the interaction 
between macronutrient metabolism 
and caffeine consumption. Further 
exploration of how macronutrient 
metabolism is impacted when 
caffeine is ingested with food was 
probed.
Results
Figure 1. Characteristics table of Published Papers of Impact of Caffeine on Macronutrient Metabolism
Carbohydrate Lipid Protein
Authors 4. Greer F, et al. 6. Johnston KL, et al. 1. Akiba T, et al. 8. Kobayashi-Hattori k, et al. 5. Jacobson TL, et al. 3. Graham TE, et al. 2. Eaton T, et al. 7. Kendall KL, et al. 
Population Tested Healthy, lean, sedentary males, 
non-smokers, not regular 
caffeine users, screened for type 
2 diabetes
Healthy adults, BMI≤25, non-
smokers, no heavy alcohol 
consumption
Mouse preadipocyte cells and mouse brown 
adipocytes
Animal Model (Rats) 
healthy highly trained male cyclists and 
triathletes
healthy individules
Football players who 
regualarly competing and 
training 
Healthy Individuals who exercise regularly 
Final Sample Size
9 9 24 well plates/cell type 44 8 10 8 17
Participant 
Characteristics
Age
25 ± 0.5 26 ± 3.2 N/A N/A 21.2±3 20-28 22 ± 2 21 ± 4
Sex
Male Male and female N/A Male Rats Male Male Male Males 
Study Design [Subjects were asked to abstain 
from all methylxanthine-
containing products for 48 h 
before each trial. For each 
subject, two catheters are used 
to infuse nutrients (normal saline, 
insulin, glucose and potassium) 
and to draw blood samples. 
Insulin was infused at a rate of 
40 mU/(m^2*min^1) for 180 min 
while 20% glucose was infused 
to keep plasma glucose 
concentration at 5.0-5.5 mmol/L. 
Upon receiving the treatment, a 
hyperinsulinemic-euglycemic
clamp procedure was performed 
drawing blood sample every 30 
min for the duration of the clamp.
Test beverages were selected 
and were reconstituted to a 
final CQA concentration of 2.50 
mmol/L, with 25g glucose. The 
day before study the subjects 
were given a sample menu high 
in carbohydrates. After fasting 
overnight, they proceeded to 
consume 400ml 
treatment/control. Blood 
samples were taken at frequent 
intervals for the next 180 min. 
Insulin, glucose- dependent 
insulinotropic polypeptide (GIP) 
and glucagon-like peptide 1 
(GLP-1) levels were analyzed.
Glucose Uptake: Primary cultured mouse 
brown adipocytes were incubated and were 
treated with caffeine (conc. 0.0, 0.1, 0.25, 0.5, 
1.0 mM ) or adenosine receptor antagonists 
with 1 hr incubation. Before being exposed (or 
not) to insulin, 2-deoxy-D-[1-³H]glucose was 
added, the cells were incubated for another 5 
min before extraction with 1N NaOH (later 
neutralized with 1N HCl). Liquid scintillation 
spectroscopy was performed to measure 
radioactivity incorporated into the cells. 
Immunoblotting: Mouse preadipocyte cells 
were incubated and treated with caffeine 
(conc. 0.1, 0.25, 0.5, 1.0 mM ) and incubated 
for 1 hr. Insulin was added and the cultures 
were incubated for 5 min, then the cells were 
lysed for immunoblot analysis. 
Experiment 1: 32 rats fed with a standard diet 
for 7 days were divided into 4 groups, pair-fed 
with a diet containing 20% lard and various 
amount of caffeine for 21 days. Blood 
samples, adipose tissues, and liver tissues 
were collected after a 7-hour fast to measure 
the serum, hapatic lipid and the total weight of 
the adipose tissues.        
Experiment 2: 12 rats fed with a standard diet 
for 7 days were divided into 2 groups. After a 
7-hour fast, distilled water and caffeine were 
orally administered to the control group and 
test group, respectively. Blood samples were 
collected at 0, 30, 60, 120 and 180 minutes 
time point after the administration. The serum 
concentrations of catecholamines were then 
determined.
Four trials were performed on each 
subject in a random order, resting blood 
sample was obtained at the first trail. In 
each trial, subjects ingested one test 
meal and blood samples were obtained 
30 and 55 minutes following ingestion; 
they then cycled at steady-state for 120 
minutes on a cycle ergometer. More 
blood samples were obtained at 20, 40, 
60, 80, 100 and 119 minutes during the 
cycling, and exhalation was collected for 
60s at 19, 39, 59, 79 and 119 minutes 
during the cycling.
Two trials, one with treatment and one with 
placebo were administered with one week in 
between. Subject abstained from all caffeinated 
foods and beverages for 48 hours and fasted 
overnight before the tests. After 30 min of supine 
rest, an arterial blood sample was taken and the 
subject ingested gelatin capsules containing 
either caffeine (6 mg/kg body wt) or placebo 
(dextrose) with 250 ml water. After another 60 
min rest the subjects exercised for 60 minutes 
on a Krogh cycle ergometer. Heart rate and 
blood pressure were recorded at 0, 10, 30, 45 
and 60 minutes. Leg blood flow was determined, 
and arterial and venous blood samples were 
drawn.
Participants performed a 
repeat sprint running protocol 
on a nonmotorized treadmill in 
an extreme environment on 4 
separate occasions. 
Participants were randomly 
assigned and ingested one of 
the 4 supplements: a double 
placebo, caffeine + placebo, 
essential amino acid (EAA) 
+placebo, or caffeine + EAA. 
Electromyography (EMG) 
activity, quadriceps evoked 
responses to magnetic 
stimulation, blood sample was 
assessed at regular intervals.
Participants were assigned to either the 
placebo or the supplement randomly. 
Participants were required to maintain 
their current diet throughout the duration 
of the study while treatment was ingested 
everyday for at least 28 days. Blood 
sample, resting heart rate, blood 
pressure, body composition assessment 
and percent fat were assessed in the 
study. Maximum volume of oxygen test 
was used to measure performance. 
Treatment Caffeine at 5mg/kg body wt in 
gelatin capsules. Control: 
placebo gelatin capsules. 
Decaffeinated coffee 400 ml, 
CQA 2.50 mmol/L, 25g glucose. 
Caffeinated coffee 400 ml, CQA 
2.50 mmol/L, 25g glucose. 
Control: water 400 ml, 25g 
glucose. 
Glucose Uptake: Caffeine/adenosine receptor 
antagonists/no treatment; insulin/no insulin 
Immunoblotting: Caffeine/no treatment; insulin
Experiment 1: An experimental diet with 0% or 
0.025% or 0.05% or 0.1% caffeine and 20% 
lard. Experiment 2: A normale diet with distilled 
water or caffeine. 
Four test meals: 1. 2.6g(kg BM) -1 of 
high glycaemic index carbohydrate 2. 
2.6g(kg BM) -1 of high glycaemic index 
carbohydrate plus 6mg caffeine 3. 1.2g 
(kg BM) -1 saturated fat 4. 1.2g (kg BM) 
-1 saturated fat plus 6mg caffeine
Two treatments, a gelatin capsules containing 
either caffeine (6 mg (kg body wt) ) or placebo 
(dextrose) with approximately 250 ml water.
a double placebo, 3 mg.kg-1 
body mass of caffeine + 
placebo, 2x1 g essential amino 
acid (EAA) (Musashi
Create)+placebo, or caffeine + 
EAA
The supplement is marketed as Assault, 
(Denver, CO, USA) contained BCAAs (6 
g), creatine (5 g), β -alanine (4 g), 
citrulline malate (1.5 g), and caffeine (300 
mg). The placebo was flavored 
maltodextrin, similar color and taste as the 
supplement. 
Outcomes Test 
Results
Glucose disposal after caffeine 
ingestion was 24% less than 
after placebo. Plasma C-peptide 
concentrations were also similar 
in both trials throughout the 180 
min clamp, they both decreased 
over time with the influx of 
exogenous insulin (C-peptite
concentration is positively 
correlated with a body's insulin 
secretion)
Plasma glucose concentration 
was higher after consumption 
of caffeinated coffee than other 
two beverages, and plasma 
insulin concentration was found 
higher after caffeinated coffee 
than decaffeinated coffee.
Glucose Uptake: Caffeine inhibited insulin-
induced 2-deoxy-D-[1-³H]glucose uptake in a 
concentration-dependent manner, but no effect 
without insulin. Immunoblotting: Analysis with 
anti-GLUT4 antibody indicated that caffeine 
inhibited the insulin-induced GLUT4 
translocation to plasma membrane. GLUT4 
translocation from intracellular space to the 
plasma membrane is primarily responsible for 
insulin-induced glucose uptake by muscle and 
adipocytes. 
Experiment 1: The intake of caffeine at 0.025, 
0.05 or 0.1% for 21 day progressively reduced 
the body fat mass and body fat percentage in 
rats fed on a high-fat diet with increasing 
administration level.                
Experiment 2: Caffeine increased the serum 
concentration of catecholamines and free fatty 
acids in rats orally administered with 5mg/kg 
caffeine while at rest.
The overall respiratory exchange ratio, 
carbohydrate oxidation, fat oxidation, 
heart rate and blood samples suggest 
that caffeine co-ingestion with 
carbohydrate had little effect on exercise 
metabolism or performance compared to 
the ingestion of carbohydrate alone; 
caffeine did not increase FA oxidation in 
exercising subjects, even when fat 
availability was optimized via fat 
ingestion. 
Caffeine enhanced lipolysis in adipose tissues; 
blood pressure, resting heart rate, serum fatty 
acid and glycerol concentration were found to 
increase after caffeine ingestion. The circulating 
adrenaline concentration also increased at rest 
following caffeine ingestion. However, muscle 
biopsy shows no differences in respiratory 
exchange ratio, leg glucose uptake, net muscle 
glycogenolysis, leg lactate release muscle 
lactate, or glucose 6-phosphate concentration 
during exercises. The treatments did not affect 
leg fatty acid uptake, glycerol release or muscle 
acetyl CoA concentration while exercising. 
Coingestion of caffeine and 
EAA appears to maintain 
muscle activation and central 
drive with a small improvement 
in running performance. The 
improvement is appeared to be 
associated with the central 
drive and muscle activation. 
Supplements that contain similar 
ingredients and doses should be safe for 
taking up to 28 days in healthy, physically 
active adolescents. Caffeine, creatine, β -
alanine, BCAA, etc can be responsible for 
the improvements in performance. The 
researcher hypothesize that the caffeine 
and creatine played a primary role. 
Aim
To investigate the benefits or risk or 
harm between caffeine and 
macronutrients consumption.
Discussion
Carbohydrate and Fat 
Figure 2. Flowchart of impact of caffeine on carbohydrate and fat 
CAFFEINE
CATECHOLAMINES
LIPOLYSIS
INSULIN RESPONSE
GLUCOSE
GLUT-4 TRANSLOCATION
BODY FAT MASS
GLUCOSE UPTAKE
reduces
PI3K pathway
ingestion
other pathways
*Caffeine was not found to affect catecholamines activity during exercise.
Protein
Few studies focused on the relationship between caffeine and protein, and the 
main focus of those studies were exercise or muscle performance instead of 
nutritional impacts. A study that reported co-ingestion of essential amino acid and 
caffeine has small improvement in running performance compared to a placebo, 
only caffeine or only essential amino acid (Kendall, Moon, Fairman 2014). Having 
both amino acid and caffeine might be beneficial for sport performance. However, 
here is a clear gap in the literature, and studies investigating the effects of caffeine 
on protein metabolism are needed.
Conclusion
All but one human-subject experiments reviewed in this study recruited only 
healthy (screened for medical history and BMI>25), young (age 18-28) males for 
their experiments. Previous medical conditions, high BMI or age variations can 
introduce significant variation in overall metabolism. The largest age range in the 
studies we examined was 8 years (age 20-28). Males were preferred over female 
subjects in the studies for consistency; even with an all-female population it is 
difficult to achieve homogeneity, due to individual menstrual positions, oral 
contraceptive use, possible pregnancy and other conditions that may affect 
metabolism on top of caffeine metabolism.
